DNA fragmentation decreased in schizophrenia but not bipolar disorder

Archives of General Psychiatry

Volumn 60, Issue 4, 2003, Pages 359-364

  Benes, Francine M ^a   Walsh, John ^b   Bhattacharyya, Sujoy ^b   Sheth, Archna ^b   Berretta, Sabina ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; SINGLE STRANDED DNA;

ADULT; AGED; APOPTOSIS; ARTICLE; BIPOLAR DISORDER; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; DNA STRAND BREAKAGE; FEMALE; HUMAN; HYPOTHESIS; INTRACELLULAR TRANSPORT; KLENOW METHOD; MALE; MITOCHONDRIAL RESPIRATION; MORPHOLOGICAL ADAPTATION; NEUROANATOMY; NEUROPATHOLOGY; NICK END LABELING; OXIDATION KINETICS; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; APOPTOSIS; BIPOLAR DISORDER; COHORT STUDIES; DNA FRAGMENTATION; ENDODEOXYRIBONUCLEASES; FEMALE; GYRUS CINGULI; HUMANS; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SCHIZOPHRENIA;

EID: 0037383536     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.4.359     Document Type: Article

References (41)

1. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia: a systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry. 1998;172:110-120.
2. Arnold SE, Trojanowski JQ. Recent advances in defining the neuropathology of schizophrenia. Acta Neuropathol (Berl). 1996;92:217-231.
3. Benes FM, McSparren J, Bird ED, Vincent SL, SanGiovanni JP. Deficits in small interneurons in prefrontal and anterior cingulate cortex of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 1991;48:996-1001.
4. Benes FM, Vincent SL, Todtenkopf MS. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry. 2001;50:395-406.
5. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressive. Biol Psychiatry. 1998;44:88-97.
6. Benes FM. Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev. 2000;31:251-69.
7. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders [review]. Science. 1993;262:689-695.
8. Jarskog LF, Gilmore JH, Selinger ES, Lieberman JA. Cortical bcl-2 protein expression and apoptotic regulation in schizophrenia. Biol Psychiatry. 2000;48:641-650.
9. Martin LJ. Neuronal cell death in nervous system development, disease, and injury [review]. Int J Mol Med. 2001;7:455-478.
10. Marti MJ, James CJ, Do TF, Kelly WJ, Burke RE. Early developmental destruction of terminals in the striatal target induces apoptosis in dopamine neurons of the substantia nigra. J Neurosci. 1997;17:2030-2039.
11. Margolis RL, Chuang DM, Post RM. Programmed cell death: implications for neuropsychiatric disorders. Biol Psychiatry. 1994;35:946-956.
12. Catts VS, Catts SV. Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res. 2000;41:405-415.
13. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol. 1998;57:1041-1052.
14. Hetts SW. To die or not to die: an overview of apoptosis and its role in disease. JAMA. 1998;279:300-307.
15. Evan G, Littlewood T. A matter of life and cell death. Science. 1998;281:1317-1322.
16. Ansari B, Coates PJ, Greenstein BD, Hall PA. In situ end-labelling detects DNA strand breaks in apoptosis and other physiological and pathological states. J Pathol. 1993;170:1-8.
17. Jin K, Chen J, Nagayama T, Chen M, Sinclair J, Graham SH, Simon RP. In situ detection of neuronal DNA strand breaks using the Klenow fragment of DNA polymerase I reveals different mechanisms of neuron death after global cerebral ischemia. J Neurochem. 1999;72:1204-1214.
18. Davidson M, Harvey P, Welsh KA, Powchik P, Putnam KM, Mohs RC. Cognitive functioning in late-life schizophrenia: a comparison of elderly schizophrenic patients and patients with Alzheimer's disease. Am J Psychiatry. 1996;153:1274-1279.
19. Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol. 1999;58:1147-1155.
20. Didier M, Bursztajn S, Adamec E, Passani L, Nixon RA, Coyle JT, Wei JY, Berman SA. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J Neurosci. 1996;16:2238-2250.
21. Adamec E, Vonsattel JP, Nixon RA. DNA strand breaks in Alzheimer's disease. Brain Res. 1999;849:67-77.
22. Rosenthal DS, Ding R, Simbulan-Rosenthal CM, Cherney B, Vanek P, Smulson M. Detection of DNA breaks in apoptotic cells utilizing the DNA binding domain of poly(ADP-ribose) polymerase with fluorescence microscopy. Nucleic Acids Res. 1997;25:1437-1441.
23. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 1992;12:924-929.
24. Lopez E, Pozas E, Rivera R, Ferrer I. Bcl-2, Bax and Bcl-x expression following kainic acid administration at convulsant doses in the rat. Neuroscience. 1999;91:1461-1470.
25. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-1312.
26. Henshall DC, Bonislawski DP, Skradski SL, Araki T, Lan JQ, Schindler CK, Meller R, Simon RP. Formation of the Apaf-1/cytochrome c complex precedes activation of caspase-9 during seizure-induced neuronal death. Cell Death Differ. 2001;8:1169-1181.
27. Gorman AM, Orrenius S, Ceccatelli S. Apoptosis in neuronal cells: role of caspases. Neuroreport. 1998;9:R49-R55.
28. Thornberry NA. Caspases: key mediators of apoptosis. Chem Biol. 1998;5:R97-R103.
29. Nunez G, Benedict MA, Hu Y, Inohara N. Caspases: the proteases of the apoptotic pathway. Oncogene. 1998;17:3237-3245.
30. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322-1326.
31. Han BH, Holtzman DM. BDNF protects the neonatal brain from hypoxic-ischemic injury in vivo via the ERK pathway. J Neurosci. 2000;20:5775-5781.
32. Takahashi M, Shirakawa O, Toyooka K, Kitamura N, Hashimoto T, Maeda K, Koizumi S, Wakabayashi K, Takahashi H, Someya T, Nawa H. Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients. Mol Psychiatry. 2000;5:293-300.
33. Lin L-FH, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130-1132.
34. Allen RT, Cluck MW, Agrawal DK. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol Life Sci. 1998;54:427-445.
35. Cory S, Adams JM. Matters of life and death: programmed cell death at Cold Spring Harbor. Biochim Biophys Acta. 1998;1377:R25-R44.
36. Gillardon F, Wickert H, Zimmermann M. Up-regulation of bax and downregulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci Lett. 1995;192:85-88.
37. Ravishankar S, Ashraf QM, Fritz K, Mishra OP, Delivoria-Papadopoulos M. Expression of Bax and Bcl-2 proteins during hypoxia in cerebral cortical neuronal nuclei of newborn piglets: effect of administration of magnesium sulfate. Brain Res. 2001;901:23-29.
38. Vukosavic S, Dubois-Dauphin M, Romero N, Przedborski S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem. 1999;73:2460-2468.
39. Middleton FA, Mirnics K, Pierri JN, Lewis DA, Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci. 2002;22:2718-2729.
40. Maurer I, Zierz S, Moller H. Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia. Schizophr Res. 2001;48:125-136.
41. Prince JA, Harro J, Blennow K, Gottfries CG, Oreland L. Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics. Neuropsychopharmacology. 2000;22:284-292.